new guidelines on using low-molecular-weight heparins (Lovenox, Fragmin, Fraxiparine, Innohep)
August 2001
The American Heart Assoc just released new guidelines on using low-molecular-weight heparins (Lovenox, Fragmin, Fraxiparine, Innohep).
The bottom line...LMW heparins are now considered FIRST-LINE for prevention and treatment of venous thromboembolism (VTE).
Lovenox (enoxaparin) and Fragmin (dalteparin) can also be used as an alternative to heparin for unstable angina.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive